Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 62,498 | 64,482 | 65,318 | 64,390 | 60,192 |
| Cost of Goods | 4,774 | 6,238 | 6,320 | 6,059 | 5,665 |
| Gross Profit | 57,724 | 58,244 | 58,998 | 58,331 | 54,527 |
| Operating Expenses | 56,494 | 51,853 | 55,410 | 54,929 | 62,861 |
| Operating Income | 2,004 | 6,629 | 3,908 | 3,461 | -7,669 |
| Other Income | 3,524 | 2,984 | 1,553 | 329 | 105 |
| Pre-tax Income | 5,528 | 9,613 | 5,461 | 3,790 | -7,564 |
| Income Tax | 2,276 | 2,752 | 2,191 | 1,216 | -1,134 |
| Net Income Continuous | 3,252 | 6,861 | 3,270 | 2,574 | -6,430 |
| Net Income | $3,252 | $6,861 | $3,270 | $2,574 | $-6,430 |
| EPS Basic Total Ops | 0.06 | 0.11 | 0.06 | 0.05 | -0.11 |
| EPS Basic Continuous Ops | 0.06 | 0.12 | 0.06 | 0.05 | -0.11 |
| EPS Diluted Total Ops | 0.06 | 0.11 | 0.06 | 0.05 | -0.11 |
| EPS Diluted Continuous Ops | 0.06 | 0.12 | 0.06 | 0.05 | -0.11 |
| EBITDA(a) | $386 | $5,489 | $3,428 | $4,072 | $-6,890 |